Arivale, the “scientific wellness” startup co-founded by genomics pioneer Lee Hood, has hired Grant Ries, the co-founder of big-data company BlueKai,… Read More
Chris Rivera is stepping down as president and CEO of the Washington Biotechnology & Biomedical Association, a nonprofit biotech trade group. He… Read More
Juno Therapeutics, a Seattle-based cancer research firm backed by Amazon founder Jeff Bezos, Arch Venture Partners and others, reported a loss… Read More
—Cyanogen, the makers of modified versions of Android for mobile devices, has snagged two executives from Amazon and Qualcomm to expand international… Read More
Five years after coming to Seattle via its purchase of ZymoGenetics, drug giant Bristol-Myers Squibb is moving 40 Seattle-based research and… Read More
A consortium that includes Seattle-based biotech company Kineta, UW Medicine, and the University of Washington’s CoMotion group is seeking to raise an… Read More
NanoString Technologies, a Seattle-based biotech company focused on developing cancer treatments, faced deepening losses this quarter as the company missed… Read More
Luke Timmerman, a respected biotechnology journalist known for his past work at The Seattle Times and Xconomy, today launched a new subscription-based biotech news… Read More
NanoString, a 12-year-old Seattle company whose tools help genetic researchers better analyze genes and molecules, is expanding its footprint in… Read More
Dendreon, a once-promising Seattle biotech company developing treatments for prostate cancer, today filed for Chapter 11 bankruptcy protection. It marks… Read More
Amgen dealt a blow to Seattle’s biotech industry last week with the announcement that it will be closing its large research-and-development campus… Read More
